Business & regional news

Month Year

Month Year

May 2, 2022

Medtronic announces first enrollment in pivotal trial of patients with moderate, symptomatic aortic stenosis

EXPAND TAVR II Pivotal Trial evaluating the Evolut™ TAVR platform in a new patient population
- Structural Heart and Aortic
Apr 28, 2022

New simulation data from the STROKE AF study shows insertable cardiac monitors detect 4 times more AF than intermittent monitoring

Heart Rhythm 2022: Sub-analysis indicates patients with intermittent monitoring may not be optimally managed for secondary stroke prevention
- Cardiovascular Diagnostics and Services
Apr 27, 2022

IN.PACT™ AV drug-coated balloon first and only to show sustained and superior performance compared to PTA through 36 months

Medtronic, the global leader in medical technology, today announced new randomized controlled data demonstrating the sustained and superior performance of IN.PACT AV drug coated balloon (DCB)...
- Peripheral Vascular Health
Apr 27, 2022

Medtronic to acquire Acutus Medical left-heart access portfolio

Medtronic today announced that it has signed an agreement with Acutus Medical Inc., a manufacturer of arrhythmia management technologies, for exclusive rights to distribute and acquire its...
- Cardiac Ablation Solutions
Apr 27, 2022

Extended Pivotal Trial Results for the MiniMed 780G system with the newest Guardian™ 4 sensor Demonstrate Sustained Improvements in Time in Range with Less User Interaction

Results were presented at the Advanced Technologies & Treatments for Diabetes (ATTD) Conference
- Diabetes
- Europe, Middle East & Africa
Apr 25, 2022

Medtronic Announces Scientific Data Presentations at The 2022 International Conference on Advanced Technologies and Treatments for Diabetes

Medtronic plc, the global leader in medical technology, today announced its participation at the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), taking...
- Diabetes
- Europe, Middle East & Africa
Apr 20, 2022

Decision makers in Europe further expand patient access for technology that simplifies diabetes management

Medtronic plc, a global leader in healthcare technology, today announced that reimbursement for its advanced insulin delivery system, MiniMed 780G, has been recently expanded across two more...
- Diabetes
- Europe, Middle East & Africa
Apr 19, 2022

Medtronic Announces Collaboration with Cydar Medical to Bring Endovascular Aortic Care to a New Level with Cutting-Edge Artificial Intelligence Technology
- Structural Heart and Aortic
Apr 15, 2022

Dov Shenkman to lead Global Supply Chain for Medtronic
- Global Operations
Apr 12, 2022

Medtronic announces upcoming market release of AI algorithms for cardiac monitoring in Europe

AccuRhythm AI algorithms shown to reduce false alerts by 84%
- Business News
- Cardiovascular Diagnostics and Services
Apr 4, 2022

Medtronic TAVR platform first and only to demonstrate durability benefit over SAVR at 5 years

ACC.22: Late-breaking data show CoreValve™ and Evolut™ is the only platform to out-perform surgery in valve durability at five years
- Structural Heart and Aortic
Mar 25, 2022

Touch Surgery™ Enterprise Wins 2022 Artificial Intelligence Award from the Business Intelligence Group
- Surgical Robotics
Mar 14, 2022

Expanded patient access for diabetes technology around the world to help simplify diabetes management
- Diabetes

Show per page